Skip to main content

Table 4 Agreements among seven classifiers discriminating an individual, evaluated using the fivefold cross validation technique

From: Statistical prediction of immunity to placental malaria based on multi-assay antibody data for malarial antigens

 

LR-Full

LR-Reduced

RPART

RF

LDA

QDA

SVM

LR-Full

 (a)

1.00

0.85

0.76

0.73

0.53

0.51

0.71

 (b)

1.00

0.87

0.79

0.77

0.52

0.51

0.74

 (c)

1.00

0.77

0.66

0.63

0.58

0.53

0.62

LR-Reduced

 (a)

0.85

1.00

0.76

0.72

0.57

0.53

0.73

 (b)

0.87

1.00

0.79

0.77

0.53

0.52

0.75

 (c)

0.77

1.00

0.67

0.58

0.70

0.58

0.65

RPART

 (a)

0.76

0.76

1.00

0.86

0.49

0.50

0.76

 (b)

0.79

0.79

1.00

0.89

0.48

0.49

0.80

 (c)

0.66

0.67

1.00

0.77

0.54

0.51

0.64

RF

 (a)

0.73

0.72

0.86

1.00

0.42

0.47

0.76

 (b)

0.77

0.77

0.89

1.00

0.41

0.47

0.80

 (c)

0.63

0.58

0.77

1.00

0.44

0.47

0.64

LDA

 (a)

0.53

0.57

0.49

0.42

1.00

0.82

0.54

 (b)

0.52

0.53

0.48

0.41

1.00

0.84

0.52

 (c)

0.58

0.70

0.54

0.44

1.00

0.74

0.61

QDA

 (a)

0.51

0.53

0.50

0.47

0.82

1.00

0.52

 (b)

0.51

0.52

0.49

0.47

0.84

1.00

0.51

 (c)

0.53

0.58

0.51

0.47

0.74

1.00

0.55

SVM

 (a)

0.71

0.73

0.76

0.76

0.54

0.52

1.00

 (b)

0.74

0.75

0.80

0.80

0.52

0.51

1.00

 (c)

0.62

0.65

0.64

0.64

0.61

0.55

1.00

  1. Based on (a). overall classification, (b). PM− classification, and (c). PM+ classification